Blueprint Medicines Corporation (BPMC)
Blueprint Medicines Corporation (BPMC) Company Bio
Blueprint Medicines Corporation makes kinase drugs to treat patients with genomically defined diseases. The company was founded in 2008 and is based in Cambridge, Massachusetts.
BPMC Stock Chart More Charts
BPMC Price/Volume Stats
| Current price | $85.74 |
| Prev. close | $84.94 |
| Day low | $85.01 |
| Day high | $87.92 |
| 50-day MA | $72.97 |
| 200-day MA | $67.67 |
| 52-week high | $105.00 |
| 52-week low | $44.58 |
| Volume | 888,900 |
| Avg. volume | 381,104 |
| Dividend yield | N/A |
| Market Cap | 3.78B |
BPMC Returns
| 1-mo | 12.68% |
| 3-mo | 53.27% |
| 6-mo | 19.72% |
| 1-year | -13.85% |
| 3-year | 403.46% |
| 5-year | N/A |
| YTD | 59.04% |
| 2018 | -28.51% |
| 2017 | 168.84% |
| 2016 | 6.49% |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...